FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:801-803 March 11, 1999 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by The Parkinson Study Group PubMed Citation

Managing psychosis is one of the most difficult challenges in the care of patients with Parkinson's disease. This complication occurs in 10 to 15 percent of such patients and consists of visual hallucinations, the belief that one is being persecuted, fears of personal endangerment, or feelings of being followed, spied on, or threatened.^1,2 Psychosis is a major source of distress for patients. It exacerbates the burdens of family members and is associated with earlier transfer to nursing homes and increased mortality.³

In managing psychosis in patients with Parkinson's disease, clinicians face a "motion–emotion" conundrum. The dopaminergic drugs that can improve . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lertxundi, U., Peral, J., Mora, O., Domingo-Echaburu, S., Martinez-Bengoechea, M. J., Garcia-Monco, J. C. (2008). Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease. Am J Health Syst Pharm 65: 414-419 [Abstract] [Full Text]  
• Leroi, I, Burns, A (2007). Behavioural and psychological symptoms of dementia associated with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78: 2-3 [Full Text]  
• Lopez-Meza, E., Ruiz-Chow, A., Ramirez-Bermudez, J. (2005). Aripiprazole in Psychosis Associated With Parkinson's Disease. J. Neuropsychiatry Clin. Neurosi. 17: 421-422 [Abstract] [Full Text]  
• Adler, C. H., Thorpy, M. J. (2005). Sleep issues in Parkinson's disease. Neurology 64: S12-S20 [Abstract] [Full Text]  
• Pollak, P, Tison, F, Rascol, O, Destee, A, Pere, J J, Senard, J M, Durif, F, Bourdeix, I (2004). Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J. Neurol. Neurosurg. Psychiatry 75: 689-695 [Abstract] [Full Text]  
• Fenelon, G., Mahieux, F., Huon, R., Ziegler, M. (2000). Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors. Brain 123: 733-745 [Abstract] [Full Text]  
• Brown, T. M., Friedman, J. H. (1999). Clozapine for Drug-Induced Psychosis in Parkinson's Disease. NEJM 341: 456-456 [Full Text]